Compile Data Set for Download or QSAR
maximum 50k data
Found 166 Enz. Inhib. hit(s) with Target = 'Integrin-linked protein kinase'
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123945(US8754233, 2-(5-Amino-3-methyl-1H-pyrazol-4-yl)-5-...)
Affinity DataIC50:  7nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124052(US8754233, 5-(3-Amino-propyl)-4-benzothiazol-2-yl-...)
Affinity DataIC50:  10nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123951(US8754233, 2-(5-Amino-3-methyl-1H-pyrazol-4-yl)-be...)
Affinity DataIC50:  10nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123930(US8754233, 2-(3-Amino-1H-pyrazol-4-yl)-5-fluoro-be...)
Affinity DataIC50:  20nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124022(US8754233, 4-Benzothiazol-2-yl-5-(3-methylamino-pr...)
Affinity DataIC50:  20nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124067(US8754233, N3-(2-Amino-ethyl)-4-benzothiazol-2-yl-...)
Affinity DataIC50:  20nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123933(US8754233, 2-(3-Amino-5-methyl-1H-pyrazol-4-yl)-5-...)
Affinity DataIC50:  40nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123992(US8754233, 4-(5-Fluoro-6-methoxy-benzothiazol-2-yl...)
Affinity DataIC50:  40nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124001(US8754233, 4-(5-Fluoro-benzothiazol-2-yl)-5-methyl...)
Affinity DataIC50:  40nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123965(US8754233, 2-(5-Amino-3-methyl-1H-pyrazol-4-yl)-be...)
Affinity DataIC50:  40nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123943(US8754233, 2-(5-Amino-3-methyl-1H-pyrazol-4-yl)-4-...)
Affinity DataIC50:  40nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123999(US8754233, 4-(5-Fluoro-6-methyl-benzothiazol-2-yl)...)
Affinity DataIC50:  50nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123946(US8754233, 2-(5-Amino-3-methyl-1H-pyrazol-4-yl)-5-...)
Affinity DataIC50:  50nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123969(US8754233, 2-(5-Amino-3-pyridin-4-yl-1H-pyrazol-4-...)
Affinity DataIC50:  50nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123942(US8754233, 2-(5-Amino-1H-pyrazol-4-yl)-benzothiazo...)
Affinity DataIC50:  60nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123994(US8754233, 4-(5-Fluoro-6-methoxy-benzothiazol-2-yl...)
Affinity DataIC50:  60nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123932(US8754233, 2-(3-Amino-5-methyl-1H-pyrazol-4-yl)-5-...)
Affinity DataIC50:  60nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124033(US8754233, 4-Benzothiazol-2-yl-5-piperidin-4-yl-2H...)
Affinity DataIC50:  60nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123996(US8754233, 4-(5-Fluoro-6-methoxy-benzothiazol-2-yl...)
Affinity DataIC50:  70nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123936(US8754233, 2-(3-Amino-5-methyl-1H-pyrazol-4-yl)-be...)
Affinity DataIC50:  70nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123931(US8754233, 2-(3-Amino-5-methyl-1H-pyrazol-4-yl)-4,...)
Affinity DataIC50:  70nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123962(US8754233, 2-(5-Amino-3-methyl-1H-pyrazol-4-yl)-be...)
Affinity DataIC50:  90nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123972(US8754233, 2-{[2-(5-Amino-3-methyl-1H-pyrazol-4-yl...)
Affinity DataIC50:  100nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124053(US8754233, 5-(4-Amino-phenyl)-4-benzothiazol-2-yl-...)
Affinity DataIC50:  100nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123925(US8754233, [2-(3-Amino-5-methyl-1H-pyrazol-4-yl)-5...)
Affinity DataIC50:  100nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124035(US8754233, 4-Benzothiazol-2-yl-5-pyridin-4-yl-2H-p...)
Affinity DataIC50:  100nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124028(US8754233, 4-Benzothiazol-2-yl-5-furan-2-yl-2H-pyr...)
Affinity DataIC50:  100nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124024(US8754233, 4-Benzothiazol-2-yl-5-(4-methylamino-bu...)
Affinity DataIC50:  100nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123993(US8754233, 4-(5-Fluoro-6-methoxy-benzothiazol-2-yl...)
Affinity DataIC50:  100nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123947(US8754233, 2-(5-Amino-3-methyl-1H-pyrazol-4-yl)-5-...)
Affinity DataIC50:  130nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124041(US8754233, 4-Benzothiazol-2-yl-N3-(2-ethylamino-et...)
Affinity DataIC50:  150nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123944(US8754233, 2-(5-Amino-3-methyl-1H-pyrazol-4-yl)-5-...)
Affinity DataIC50:  150nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124032(US8754233, 4-Benzothiazol-2-yl-5-piperazin-1-yl-2H...)
Affinity DataIC50:  190nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124009(US8754233, 4-(6-Fluoro-benzothiazol-2-yl)-1H-pyraz...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124013(US8754233, 4-(6-Methoxy-benzothiazol-2-yl)-5-piper...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124021(US8754233, 4-Benzothiazol-2-yl-5-(3-dimethylamino-...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123960(US8754233, 2-(5-Amino-3-methyl-1H-pyrazol-4-yl)-be...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123948(US8754233, 2-(5-Amino-3-methyl-1H-pyrazol-4-yl)-be...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123952(US8754233, 2-(5-Amino-3-methyl-1H-pyrazol-4-yl)-be...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123998(US8754233, 4-(5-Fluoro-6-methoxy-benzothiazol-2-yl...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123997(US8754233, 4-(5-Fluoro-6-methoxy-benzothiazol-2-yl...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124055(US8754233, 5-Methyl-4-(4,5,6-trifluoro-benzothiazo...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123973(US8754233, 3-(5-Amino-4-benzothiazol-2-yl-1H-pyraz...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124008(US8754233, 4-(6-Dimethylaminomethyl-benzothiazol-2...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124004(US8754233, 4-(6-Bromo-5-fluoro-benzothiazol-2-yl)-...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM124069(US8754233, N3-(3-Dimethylamino-propyl)-4-(5-fluoro...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123963(US8754233, 2-(5-Amino-3-methyl-1H-pyrazol-4-yl)-be...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123923(US8754233, (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[...)
Affinity DataIC50:  200nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123935(US8754233, 2-(3-Amino-5-methyl-1H-pyrazol-4-yl)-be...)
Affinity DataIC50:  300nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin-linked protein kinase(Homo sapiens (Human))
Dermira (Canada)

US Patent
LigandPNGBDBM123950(US8754233, 2-(5-Amino-3-methyl-1H-pyrazol-4-yl)-be...)
Affinity DataIC50:  300nMT: 2°CAssay Description:5 uL of each compound dilution were robotically pipetted to Costar serocluster plates maintaining the same plate layout. All assay mixtures consisted...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 166 total ) | Next | Last >>
Jump to: